Synchronus Bilateral Breast Carcinoma (SBBC): A cytological diagnosis with review of literature

Anita Javalgi,Swathi Arora,Surekha Arakeri

doi:10.7439/ijbr.v5i8.700

Abstract

Introduction : A second primary breast cancer in the opposite breast can be either synchronous or metachronous. Bilateral synchronous breast cancer is defined as both cancers diagnosed within 3 months and neither can originate with metastasis from another tumour. Case Report : 40 year old female visited with complaint of mass in right breast and ulcer in left breast since 20 days with enlarged right axillary and left supraclavicular lymph nodes since last 2 months. Patient was referred for cytology of both lumps and lymphnodes. Cytological study of both lumps shown features of invasive duct carcinoma and lymph nodes shown metastatic deposits of carcinoma with similar morphological features as of breast lumps. Based on clinical presentation and cytological study case was diagnosed as synchronous invasive duct carcinoma. Conclusion : Synchronous breast cancer has poor prognosis hence early cytological and mammography detection helps in prompt management and thus decreasing morbidity as well as mortality.

Highlights

A second primary breast cancer in the opposite breast can be either synchronous or metachronous
Increasing breast cancer incidence rates, improved prognosis, and growing life expectancy have resulted in increasing number of women at risk of developing a bilateral primary breast cancer.[1]
There are only limited data on incidence rates of synchronous and metachronous breast cancer, [2,3] results on temporal trends in incidence are conflicting,[4] and little is known about the prognostic outlook after treatment of a second primary cancer. [5,6]

Summary

Introduction

A second primary breast cancer in the opposite breast can be either synchronous or metachronous. Bilateral synchronous breast cancer is defined as both cancers diagnosed within 3 months and neither can originate with metastasis from another tumour. Increasing breast cancer incidence rates, improved prognosis, and growing life expectancy have resulted in increasing number of women at risk of developing a bilateral primary breast cancer.[1]. [1] optimal surveillance and clinical management of women who have had one or two primary breast cancers is a challenge. There are only limited data on incidence rates of synchronous and metachronous breast cancer, [2,3] results on temporal trends in incidence are conflicting,[4] and little is known about the prognostic outlook after treatment of a second primary cancer. There are only limited data on incidence rates of synchronous and metachronous breast cancer, [2,3] results on temporal trends in incidence are conflicting,[4] and little is known about the prognostic outlook after treatment of a second primary cancer. [5,6]

Case Report

Discussion

Conclusion